Patent Law in Biotechnology, Chemicals & Pharmaceuticals

Patent Law in Biotechnology, Chemicals & Pharmaceuticals

Author: Harold C. Wegner

Publisher: Springer

Published: 1992-03-23

Total Pages: 524

ISBN-13: 1349219584

DOWNLOAD EBOOK

A practical guide to patent prosecution and strategy in the US with particular reference to invention in chemicals and biotechnology. The presentation is focused on case law in the US and deals with specific cases. A section is devoted to international patent protection.


The Chemist's Companion Guide to Patent Law

The Chemist's Companion Guide to Patent Law

Author: Chris P. Miller

Publisher: John Wiley & Sons

Published: 2011-03-01

Total Pages: 538

ISBN-13: 1118035194

DOWNLOAD EBOOK

Written by an individual with experience as both a chemist and a patent attorney, The Chemist's Companion Guide to Patent Law covers everything the student or working chemist needs to know about patentability, explaining important concepts of patent law (such as novelty, non-obviousness, and freedom-to-operate) in easy-to-understand terms. Through abundant examples from case law as well as real-world situations with which a researcher might be faced, this book provides readers with a better understanding of how to put that knowledge into practice.


Current Catalog

Current Catalog

Author: National Library of Medicine (U.S.)

Publisher:

Published: 1970

Total Pages: 1040

ISBN-13:

DOWNLOAD EBOOK

Includes subject section, name section, and 1968-1970, technical reports.


Innovation and Patent Law Reform

Innovation and Patent Law Reform

Author: United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts, Civil Liberties, and the Administration of Justice

Publisher:

Published: 1985

Total Pages: 988

ISBN-13:

DOWNLOAD EBOOK


The Generic Challenge

The Generic Challenge

Author: Martin A. Voet

Publisher: BrownWalker Press

Published: 2020-05-01

Total Pages: 240

ISBN-13: 1627347461

DOWNLOAD EBOOK

This Sixth Edition of The Generic Challenge provides important new updates on current regulatory, legal and commercial issues affecting brand and generic pharmaceutical products, including new laws establishing generics for biologics, and changes brought about by the recently enacted America Invents Act. It explains clearly and understandably the roles of patents, FDA regulation of drugs and the Hatch Waxman Act in commercial drug development in light of generic challenges and how improvements in innovative drug products provide benefits to patients while extending the commercial lives of the drugs. There is simply no other book of its kind on this important subject.